2-(4-Allyl-5-((2-chlorobenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine

Catalog No. :
ACQNUJ311
CAS No. :
575461-53-9
Molecular Formula :
C17H15ClN4S
Molecular Weight :
342.86

IUPAC Name:2-(4-allyl-5-((2-chlorobenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine

2-(4-Allyl-5-((2-chlorobenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Allyl-5-((2-chlorobenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine
IUPAC Name2-(4-allyl-5-((2-chlorobenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine
MDL No.MFCD04026713
Molecular FormulaC17H15ClN4S
Molecular Weight342.86
SMILESClC1=CC=CC=C1CSC2=NN=C(C3=NC=CC=C3)N2CC=C
InChI KeyFZOXMUGXADRFAX-UHFFFAOYSA-N
SynonymSALOR-INT L415316-1EA;2-(4-ALLYL-5-((2-CHLOROBENZYL)THIO)-4H-1,2,4-TRIAZOL-3-YL)PYRIDINE;2-[5-[(2-chlorophenyl)methylsulfanyl]-4-prop-2-enyl-1,2,4-triazol-3-yl]pyridine;Pyridine, 2-[5-[[(2-chlorophenyl)methyl]thio]-4-(2-propen-1-yl)-4H-1,2,4-triazol-3-yl]-
CAS No.575461-53-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQNUJ311 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQNUJ311 route product structure diagram
    ACQNUJ311575461-53-9
Inquiry

2. ACQNUJ311 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQNUJ311 route product structure diagram
    ACQNUJ311575461-53-9
Inquiry

Comments (0)